Function of ERBB4 is determined by alternative splicing

被引:86
作者
Veikkolainen, Ville [1 ,2 ,3 ]
Vaparanta, Katri [1 ,2 ]
Halkilahti, Kalle [1 ,2 ]
Iljin, Kristiina [4 ]
Sundvall, Maria [1 ,2 ,5 ]
Elenius, Klaus [1 ,2 ,5 ]
机构
[1] Univ Turku, Dept Med Biochem & Genet, Turku, Finland
[2] Univ Turku, MediCity Res Lab, Turku, Finland
[3] Turku Grad Sch Biomed Sci, Turku, Finland
[4] VTT Tech Res Ctr, Turku, Finland
[5] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland
基金
芬兰科学院;
关键词
EGFR; HER4; isoforms; alternative splicing; cancer; non-neoplastic diseases; EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; BREAST-CANCER CELLS; INTRACELLULAR DOMAIN 4ICD; DEPENDENT GAMMA-SECRETASE; ESTROGEN-RECEPTOR; IN-VIVO; CHILDHOOD MEDULLOBLASTOMA; DIFFERENTIAL EXPRESSION; NUCLEAR-LOCALIZATION;
D O I
10.4161/cc.10.16.17194
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alternative splicing is a central tool of evolution that significantly increases the size of transcriptomes and generates functional specification. Within the human ERBB receptor gene family, only ERBB4 is known to produce functionally distinct isoforms as a result of alternative splicing. While ErbB4 signaling has been demonstrated to regulate cellular processes involved in embryogenesis, carcinogenesis, and cardiovascular and psychiatric diseases, relatively little is known about the contribution of the individual isoforms in the different biological contexts. Here we review recent findings as well as provide novel data about the distribution and functions of the ERBB4 splice variants. These observations represent an example of how minor alterations in the transcripts of a single gene can result in even antagonistic cellular responses. The observations also underline the significance of understanding the unique functions of isoforms of a potential drug target gene.
引用
收藏
页码:2647 / 2657
页数:11
相关论文
共 94 条
  • [1] Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity
    Ancot, F.
    Foveau, B.
    Lefebvre, J.
    Leroy, C.
    Tulasne, D.
    [J]. ONCOGENE, 2009, 28 (22) : 2185 - 2195
  • [2] WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function
    Aqeilan, RI
    Donati, V
    Palamarchuk, A
    Trapasso, F
    Kaou, M
    Pekarsky, Y
    Sudol, M
    Croce, CM
    [J]. CANCER RESEARCH, 2005, 65 (15) : 6764 - 6772
  • [3] Association of Wwox with ErbB4 in breast cancer
    Aqeilian, Rami I.
    Donati, Valentina
    Gaudio, Eugenio
    Nicoloso, Milena S.
    Sundvall, Maria
    Korhonen, Anna
    Lundin, Johan
    Isola, Jorma
    Sudol, Marius
    Joensuu, Heikki
    Croce, Carlo M.
    Elenius, Klaus
    [J]. CANCER RESEARCH, 2007, 67 (19) : 9330 - 9336
  • [4] Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment
    Arasada, RR
    Carpenter, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) : 30783 - 30787
  • [5] Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome
    Banerjee, Anamika
    MacDonald, Mathew L.
    Borgmann-Winter, Karin E.
    Hahn, Chang-Gyu
    [J]. BRAIN RESEARCH BULLETIN, 2010, 83 (3-4) : 132 - 139
  • [6] Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury
    Bersell, Kevin
    Arab, Shima
    Haring, Bernhard
    Kuehn, Bernhard
    [J]. CELL, 2009, 138 (02) : 257 - 270
  • [7] ErbB-4: mechanism of action and biology
    Carpenter, G
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) : 66 - 77
  • [8] Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
    Carraway, KL
    Weber, JL
    Unger, MJ
    Ledesma, J
    Yu, N
    Gassmann, M
    Lai, C
    [J]. NATURE, 1997, 387 (6632) : 512 - 516
  • [9] Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients
    Chong, Victor Z.
    Thompson, Mia
    Beltaifa, Senda
    Webster, Maree J.
    Law, Amanda J.
    Weickert, Cynthia Shannon
    [J]. SCHIZOPHRENIA RESEARCH, 2008, 100 (1-3) : 270 - 280
  • [10] Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
    David, Charles J.
    Manley, James L.
    [J]. GENES & DEVELOPMENT, 2010, 24 (21) : 2343 - 2364